These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 31053132)
1. Systematic characterization of germline variants from the DiscovEHR study endometrial carcinoma population. Miller JE; Metpally RP; Person TN; Krishnamurthy S; Dasari VR; Shivakumar M; Lavage DR; Cook AM; Carey DJ; Ritchie MD; Kim D; Gogoi R; BMC Med Genomics; 2019 May; 12(1):59. PubMed ID: 31053132 [TBL] [Abstract][Full Text] [Related]
2. Germline Mutations for Novel Candidate Predisposition Genes in Sporadic Schwannomatosis. Min BJ; Kang YK; Chung YG; Seo ME; Chang KB; Joo MW Clin Orthop Relat Res; 2020 Nov; 478(11):2442-2450. PubMed ID: 32281771 [TBL] [Abstract][Full Text] [Related]
3. Exome-Wide Rare Variant Analysis From the DiscovEHR Study Identifies Novel Candidate Predisposition Genes for Endometrial Cancer. Shivakumar M; Miller JE; Dasari VR; Gogoi R; Kim D Front Oncol; 2019; 9():574. PubMed ID: 31338326 [TBL] [Abstract][Full Text] [Related]
4. A Genome-First Approach to Characterize DICER1 Pathogenic Variant Prevalence, Penetrance, and Phenotype. Mirshahi UL; Kim J; Best AF; Chen ZE; Hu Y; Haley JS; Golden A; Stahl R; Manickam K; Carr AG; Harney LA; Field A; Hatton J; Schultz KAP; Bauer AJ; Hill DA; Rosenberg PS; Murray MF; Carey DJ; Stewart DR JAMA Netw Open; 2021 Feb; 4(2):e210112. PubMed ID: 33630087 [TBL] [Abstract][Full Text] [Related]
5. Lynch syndrome identification in a Brazilian cohort of endometrial cancer screened by a universal approach. Rosa RCA; Santis JO; Teixeira LA; Molfetta GA; Dos Santos JTT; Ribeiro VDS; Chahud F; Ribeiro-Silva A; Brunaldi MO; Silva WA; Ferraz VEF Gynecol Oncol; 2020 Oct; 159(1):229-238. PubMed ID: 32694065 [TBL] [Abstract][Full Text] [Related]
8. Rare germline variants in childhood cancer patients suspected of genetic predisposition to cancer. Sylvester DE; Chen Y; Grima N; Saletta F; Padhye B; Bennetts B; Wright D; Krivanek M; Graf N; Zhou L; Catchpoole D; Kirk J; Latchoumanin O; Qiao L; Ballinger M; Thomas D; Jamieson R; Dalla-Pozza L; Byrne JA Genes Chromosomes Cancer; 2022 Feb; 61(2):81-93. PubMed ID: 34687117 [TBL] [Abstract][Full Text] [Related]
9. Germline mutations in candidate predisposition genes in individuals with cutaneous melanoma and at least two independent additional primary cancers. Pritchard AL; Johansson PA; Nathan V; Howlie M; Symmons J; Palmer JM; Hayward NK PLoS One; 2018; 13(4):e0194098. PubMed ID: 29641532 [TBL] [Abstract][Full Text] [Related]
10. Impact of gene-specific germline pathogenic variants on presentation of endometrial cancer in Lynch syndrome. Bogani G; Ricci MT; Vitellaro M; Ditto A; Chiappa V; Raspagliesi F Int J Gynecol Cancer; 2019 May; 29(4):705-710. PubMed ID: 30772826 [TBL] [Abstract][Full Text] [Related]
11. The prevalence of germline DICER1 pathogenic variation in cancer populations. Kim J; Schultz KAP; Hill DA; Stewart DR Mol Genet Genomic Med; 2019 Mar; 7(3):e555. PubMed ID: 30672147 [TBL] [Abstract][Full Text] [Related]
13. Genetic Analysis of Functional Rare Germline Variants across Nine Cancer Types from an Electronic Health Record Linked Biobank. Shivakumar M; Miller JE; Dasari VR; Zhang Y; Lee MTM; Carey DJ; Gogoi R; Kim D; Cancer Epidemiol Biomarkers Prev; 2021 Sep; 30(9):1681-1688. PubMed ID: 34244158 [TBL] [Abstract][Full Text] [Related]
14. MLH1/PMS2-deficient Endometrial Carcinomas in a Universally Screened Population: MLH1 Hypermethylation and Germline Mutation Status. Kurpiel B; Thomas MS; Mubeen M; Ring KL; Modesitt SC; Moskaluk CA; Mills AM Int J Gynecol Pathol; 2022 Jan; 41(1):1-11. PubMed ID: 33577226 [TBL] [Abstract][Full Text] [Related]
15. Co-Occurrence of Familial Non-Medullary Thyroid Cancer (FNMTC) and Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Associated Tumors-A Cohort Study. Aswath K; Welch J; Gubbi S; Veeraraghavan P; Avadhanula S; Gara SK; Dikoglu E; Merino M; Raffeld M; Xi L; Kebebew E; Klubo-Gwiezdzinska J Front Endocrinol (Lausanne); 2021; 12():653401. PubMed ID: 34326811 [TBL] [Abstract][Full Text] [Related]
16. Higher-than-expected population prevalence of potentially pathogenic germline TP53 variants in individuals unselected for cancer history. de Andrade KC; Mirabello L; Stewart DR; Karlins E; Koster R; Wang M; Gapstur SM; Gaudet MM; Freedman ND; Landi MT; Lemonnier N; Hainaut P; Savage SA; Achatz MI Hum Mutat; 2017 Dec; 38(12):1723-1730. PubMed ID: 28861920 [TBL] [Abstract][Full Text] [Related]
17. Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testing. Buchanan DD; Tan YY; Walsh MD; Clendenning M; Metcalf AM; Ferguson K; Arnold ST; Thompson BA; Lose FA; Parsons MT; Walters RJ; Pearson SA; Cummings M; Oehler MK; Blomfield PB; Quinn MA; Kirk JA; Stewart CJ; Obermair A; Young JP; Webb PM; Spurdle AB J Clin Oncol; 2014 Jan; 32(2):90-100. PubMed ID: 24323032 [TBL] [Abstract][Full Text] [Related]
18. Unexpected cancer-predisposition gene variants in Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome patients without underlying germline PTEN mutations. Yehia L; Ni Y; Sesock K; Niazi F; Fletcher B; Chen HJL; LaFramboise T; Eng C PLoS Genet; 2018 Apr; 14(4):e1007352. PubMed ID: 29684080 [TBL] [Abstract][Full Text] [Related]
19. Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort. Waszak SM; Northcott PA; Buchhalter I; Robinson GW; Sutter C; Groebner S; Grund KB; Brugières L; Jones DTW; Pajtler KW; Morrissy AS; Kool M; Sturm D; Chavez L; Ernst A; Brabetz S; Hain M; Zichner T; Segura-Wang M; Weischenfeldt J; Rausch T; Mardin BR; Zhou X; Baciu C; Lawerenz C; Chan JA; Varlet P; Guerrini-Rousseau L; Fults DW; Grajkowska W; Hauser P; Jabado N; Ra YS; Zitterbart K; Shringarpure SS; De La Vega FM; Bustamante CD; Ng HK; Perry A; MacDonald TJ; Hernáiz Driever P; Bendel AE; Bowers DC; McCowage G; Chintagumpala MM; Cohn R; Hassall T; Fleischhack G; Eggen T; Wesenberg F; Feychting M; Lannering B; Schüz J; Johansen C; Andersen TV; Röösli M; Kuehni CE; Grotzer M; Kjaerheim K; Monoranu CM; Archer TC; Duke E; Pomeroy SL; Shelagh R; Frank S; Sumerauer D; Scheurlen W; Ryzhova MV; Milde T; Kratz CP; Samuel D; Zhang J; Solomon DA; Marra M; Eils R; Bartram CR; von Hoff K; Rutkowski S; Ramaswamy V; Gilbertson RJ; Korshunov A; Taylor MD; Lichter P; Malkin D; Gajjar A; Korbel JO; Pfister SM Lancet Oncol; 2018 Jun; 19(6):785-798. PubMed ID: 29753700 [TBL] [Abstract][Full Text] [Related]
20. Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma. Mirabello L; Zhu B; Koster R; Karlins E; Dean M; Yeager M; Gianferante M; Spector LG; Morton LM; Karyadi D; Robison LL; Armstrong GT; Bhatia S; Song L; Pankratz N; Pinheiro M; Gastier-Foster JM; Gorlick R; de Toledo SRC; Petrilli AS; Patino-Garcia A; Lecanda F; Gutierrez-Jimeno M; Serra M; Hattinger C; Picci P; Scotlandi K; Flanagan AM; Tirabosco R; Amary MF; Kurucu N; Ilhan IE; Ballinger ML; Thomas DM; Barkauskas DA; Mejia-Baltodano G; Valverde P; Hicks BD; Zhu B; Wang M; Hutchinson AA; Tucker M; Sampson J; Landi MT; Freedman ND; Gapstur S; Carter B; Hoover RN; Chanock SJ; Savage SA JAMA Oncol; 2020 May; 6(5):724-734. PubMed ID: 32191290 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]